Recent events for Abbott Laboratories (NYSE:ABT) include the integration of Beta Bionics' iLet Bionic Pancreas with Abbott's sensor technology and a partnership with the Department of Health - Abu ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Abbott Laboratories isn’t one to shy away from collaborations in the diabetes space. After all, the Abbott Park, IL-based ...

Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...

Abbott Laboratories (NYSE: ABT) is one of the 17 stocks that Jim Cramer commented on. During the episode, Cramer was bullish ...

Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc.

AUSTIN, Texas — Gov. Greg Abbott has just days left to decide on Senate Bill 3, legislation that would ban the sale of THC products across Texas. If he doesn’t act by Sunday, the bill automatically ...

In the Legislature’s sloppy law attempting to ban cannabis products with THC, the punishment could be worse than the crime. | ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Oppenheimer isn’t budging on its $140 price target for Abbott Labs, clearly still smitten with the company's Volt system and ...

Abbott Labs received a confidence boost from Oppenheimer, which stuck to its $140 price target and Outperform rating. The ...